Top Ten Facts about Biotech/GM Crops in 2012

A new overview of biotech crops in 2012

Fact 1.
2012 was the 17th year of successful commercialization of biotech crops.

Biotech crops were first commercialized in 1996, and planting increased every single year between 1996 to 2012 with 12 years of double digit growth rates, reflecting the confidence and trust of millions of risk-averse farmers from both developing and industrial countries around the world.

Fact 2.
Biotech crop hectares increased by unprecedented 100-fold from 1.7 million hectares in 1996 to over 170 million hectares in 2012.

This makes biotech crops the fastest adopted crop technology in recent times. The reason – they deliver benefits. In 2012, hectarage of biotech crops grew at an annual growth rate of 6%, up 10.3 million from 160 million hectares in 2011. Millions of farmers in almost 30 countries worldwide have made more than 100 million independent decisions to plant an accumulated hectarage of almost 1.5 billion hectares, equivalent to 50% more than the total land mass of the United States or China. This growth reflects the fact that biotech crops deliver sustainable and substantial socioeconomic and environmental benefits.

Fact 3.
For the first time in 2012, developing countries planted more biotech crops than industrial countries.

Notably, developing countries grew more, 52%, of global biotech crops in 2012 than industrial countries at 48%. In 2012, growth rate for biotech crops was at least three times as fast, and five times as large in developing countries, at 11% or 8.7 million hectares, versus 3% or 1.6 million hectares in industrial countries.

Fact 4.
Number of countries growing biotech crops.

Of the 28 countries which planted biotech crops in 2012, 20 were developing and 8 were industrial countries; two new countries, Sudan (Bt cotton) and Cuba (Bt maize) planted biotech crops for the first time in 2012. Germany and Sweden could not plant the biotech potato "Amflora" because it ceased to be marketed. Stacked traits are an important feature – 13 countries planted biotech crops with two or more traits in 2012, and notably, 10 of the 13 were developing countries – 43.7 million hectares, or more than a quarter, of the 170 million hectares were stacked in 2012.

Fact 5.
Number of farmers growing biotech crops.

In 2012, a record 17.3 million farmers, up 0.6 million from 2011, grew biotech crops – remarkably over 90%, or over 15 million, were small resource-poor farmers in developing countries. Farmers are the masters of risk-aversion and in 2012, a record 7.2 million small farmers in China and another 7.2 million in India, elected to plant almost 15 million hectares of Bt cotton, because of the significant benefits it offers. In 2012 over one-third of a million small farmers in the Philippines benefited from biotech maize.

Bt cotton farmer in India.

Workers in cotton processing facility in China.

Biotech corn harvest in northern Philippines.

Fact 6.
The top 5 countries planting biotech crops.

The US continued to be the lead country with 69.5 million hectares, with an average ~ 90% adoption across all crops. Brazil was ranked second, and for the fourth consecutive year, was the engine of growth globally, increasing its hectarage of biotech crops more than any other country – an impressive record increase of 6.3 million hectares, up 21% from 2011, reaching 36.6 million hectares. Argentina retained its third place with 23.9 million hectares. Canada was fourth at 11.8 million hectares with 8.4 million hectares of canola at a record 97.5% adoption. India was fifth, growing a record 10.8 million hectares of Bt cotton with an adoption rate of 93%, In 2012, each of the top 10 countries planted more than 1 million hectares providing a broad foundation for future growth.

Fact 7.
Status of biotech crops in Africa.

The continent continued to make progress with South Africa increasing its biotech area by a record 0.6 million hectares to reach 2.9 million hectares; Sudan joined South Africa, Burkina Faso and Egypt, to bring the total number of African biotech countries commercializing biotech crops to four. Five countries, Cameroon, Kenya, Malawi, Nigeria and Uganda conducted field trials of biotech crops, the penultimate step prior to approval for commercialization. The lack of appropriate, science-based and cost/time-effective regulatory systems continue to be the major constraint to adoption. Responsible, rigorous but not onerous, regulation is needed, particularly for small and poor developing countries.

Fact 8.
Status of biotech crops in EU.

Five EU countries planted a record 129,071 hectares of biotech Bt maize, up 13% from 2011. Spain led the EU with 116,307 hectares of Bt maize, up 20% from 2011 with a record 30% adoption rate in 2012.

Fact 9.
Benefits offered by biotech crops.

From 1996 to 2011, biotech crops contributed to Food Security, Sustainability and the Environment/Climate Change by: increasing crop production valued at US$98.2 billion; providing a better environment, by saving 473 million kg a.i. of pesticides; in 2011 alone reducing CO2 emissions by 23.1 billion kg, equivalent to taking 10.2 million cars off the road for one year; conserving biodiversity by saving 108.7 million hectares of land; and helped alleviate poverty for >15.0 million small farmers and their families totaling >50 million people, who are some of the poorest people in the world. Biotech crops are essential but are not a panacea and adherence to good farming practices such as rotations and resistance management, are a must for biotech crops as they are for conventional crops.

Fact 10.
Future prospects.

Cautiously optimistic with more modest annual gains likely due to the already high rates of adoption in the principal biotech crops in mature markets in both developing and industrial countries.


For more information about ISAAA, the Global Status of Commercialized Biotech/GM Crops Briefs, and other information resources, visit the ISAAA website at http://www.isaaa.org/.

Islamic Scholars and Scientists Present Resolutions on Modern Biotechnology

Religious scholars have a tremendous potential in helping the public towards understanding biotechnology. In most countries, religious scholars have great public trust and considered as credible sources of information during time of crisis or when emerging technologies start to have impact on everyday life. Mosques and churches often become platforms for discussion and deliberation of such issues. Religious scholars are also often consulted by the government on issues related to bioethics and halal status of biotechnology products.

However, there is limited dialogue and discussion between scientists and religious scholars which creates a knowledge and communication barrier between the two groups. For religious scholars to play an effective role in addressing public concerns and ethical issues related to modern biotechnology, consultation between scientists and religious scholars has to be an ongoing process.

A workshop was organized with a focus on agribiotechnology and Muslim scholars to begin engagement of religious scholars with modern biotechnology. With Malaysia being a predominantly Muslim country, and with Shariah law governing the life of every Muslim, this was an obvious choice. All Muslim countries are far from being self-sufficient in terms of food production. Being net importers of food and with the yearly increase in the cultivation of genetically modified (GM) crops, the halal status of foods from GM crops becomes a topical issue. A record of 15.4 million farmers in 29 countries planted GM crops on 148 million hectares of land. The four main crops are soybean, cotton, canola and corn. These four crops give rise to hundreds of products that are used in almost every food consumed daily. Therefore, there is a strong and valid need to evaluate the halal status of products that comes from GM technology. The scientists involved in agricultural biotechnology too, have to understand the concerns and needs of the Muslim community who make up more than 20 per cent of the global population.

Religious scholars and Muslim scientists from Malaysia, Indonesia, Philippines, Iran, Saudi Arabia, Egypt, and the USA converged to discuss agribiotechnology and its permissibility in Islam in Georgetown, Penang, Malaysia on December 1 and 2, 2010. High level discussion on the technicality of recombinant technology and principles of shariah took place which resulted in the adoption of a resolution that states the halal status of GM products, the need for modern biotechnology in the Muslim world and the obligation of Muslim community in harnessing this beneficial technology.

Malaysia Biotechnology Information Center (MABIC), the International Halal Integrity Alliance (IHIA), and ISAAA co-organized the international workshop with a focus on alleviating the existing food problems and poverty. The International Workshop of Islamic Scholars and Experts in Modern Biotechnolgy on “Agri-biotechnology: Shariah Compliance” agreed upon the following resolutions:

1. Islam and science are complementary and Islam supports beneficial scientific innovations for mankind. Modern biotechnology and genetic engineering are important developments that merit promotion in all OIC Members. Regulatory measures should facilitate the acceptance and use of GM products particularly by Muslims. Genetic modification and GM products are Halal as long as the sources from which they originate are Halal. The only Haram cases are limited to products derived from Haram origin retaining their original characteristics that are not substantially changed.
2. Modern biotechnology and genetic engineering are methods of plant improvement and intrinsically are not different from other plant improvement techniques from the shariah point of view.
3. In ensuring food security, our Islamic obligations require us to urge all Muslim countries, governments, international organizations and research institutions, to support research and development and use of modern biotechnology, genetic engineering and their products.
4. Because of their positive impacts on agriculture and the urgency of food security for Muslim Ummah, promotion of modern biotechnology and genetic engineering are considered “Fardhu Kifayah” (collective obligation) and should not be neglected from the shariah point of view.
5. Public awareness and education on modern biotechnology and genetic engineering, demand continuous interaction between the Islamic scholars, scientists and the general public.
6. Transparent and complete scientific information should be available for the interested stakeholders for informed decision making.

The proceedings of this international workshop is available for free download at http://www.isaaa.org/resources/publications/shariah_compliance/download/default.asp

For more information materials, visit the biotech information resources page at ISAAA's websitehere: http://www.isaaa.org/resources/default.asp.